Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | N/A | +23.40% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.29 | N/A | +23.40% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting effective cost management. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
We remain focused on our long-term growth strategy.
Despite beating EPS expectations by a significant margin, Prestige Consumer HE's stock fell by 7.12% in reaction to the earnings report. Investors may have been disappointed by the lack of revenue details and forward guidance. The cautious tone from management could also have contributed to the stock's decline.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SBA COMMUNICATIONS C Class A REIT
Aug 1, 2011